Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 3
Submit an article Journal homepage
164
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response monitoring of infant acute myeloid leukemia treatment by quantification of the tumor specific MLL–FNBP1 fusion gene

Manuela KrumbholzDepartment of Pediatrics, University Hospital Erlangen, Erlangen, GermanyCorrespondence[email protected]
,
Ronny JungDepartment of Pediatrics, University Hospital Erlangen, Erlangen, Germany
,
Jutta BradtkeOncogenetic Laboratory, Molecular Pathology, Institute of Pathology, University Hospital Giessen and Marburg, Giessen, Germany
,
Dirk ReinhardtPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
,
Daniel StachelDepartment of Pediatrics, University Hospital Erlangen, Erlangen, Germany
&
Markus MetzlerDepartment of Pediatrics, University Hospital Erlangen, Erlangen, Germany
Pages 793-796 | Received 28 Feb 2014, Accepted 21 May 2014, Published online: 17 Jul 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Benjamin Tomlinson & Hillard M. Lazarus. (2017) Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making. Expert Review of Hematology 10:6, pages 563-574.
Read now

Articles from other publishers (3)

Thibault Kervarrec, Bastien Jean-Jacques, Daniel Pissaloux, Franck Tirode & Arnaud de la Fouchardière. (2021) FNBP1-BRAF fusion in a primary melanoma of the lung. Pathology 53:6, pages 785-788.
Crossref
Manuela Krumbholz, Abbas Agaimy, Robert Stoehr, Maximilian Burger, Sven Wach, Helge Taubert, Bernd Wullich, Arndt Hartmann & Markus Metzler. (2019) Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer . Disease Markers 2019, pages 1-8.
Crossref
M Krumbholz, J Bradtke, D Stachel, O Peters, B Hero, W Holter, R Slany & M Metzler. (2015) From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML. Bone Marrow Transplantation 50:10, pages 1382-1384.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.